Morphological and biochemical correlations of abnormal tau filaments in progressive supranuclear palsy

Journal of Neuropathology and Experimental Neurology

Volumn 61, Issue 1, 2002, Pages 33-45

  Takahashi, M ^a   Weidenheim, K M ^a   Dickson, D W ^a   Ksiezak Reding, H ^a  

^a NONE   (Japan)

Author keywords

Biochemical tau mapping; Glial lesions; Paired helical filaments; Progressive supranuclear palsy; Tau inclusions; Tau phosphorylation; Ultrastructure

Indexed keywords

TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CASE REPORT; CELL ULTRASTRUCTURE; CEREBELLUM; FEMALE; FRONTAL LOBE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN PHOSPHORYLATION; WHITE MATTER;

EID: 0036135106     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/61.1.33     Document Type: Article

References (58)

1. Progressive supranuclear palsy
2. Prevalence and natural history of progressive supranuclear palsy
3. Filamentous nerve cell inclusions in neurodegenerative diseases
4. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration
5. Astrocytes in other neurodegenerative diseases
6. Astrocytic pathology in progressive supranuclear palsy: Significance for neuropathological diagnosis
7. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)
8. Morphologic difference of neuropil threads in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy: A morphometric study
9. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy
10. Cortical degeneration in progressive supranuclear palsy. A comparison with corticalbasal ganglionic degeneration
11. Thornshaped astrocytes: Possibly secondary induced tau-positive glial fibrillary tangles
12. Further observations on Tau-positive glia in the brains with progressive supranuclear palsy
13. Neurodegenerative disorders with extensive tau pathology: A comparative study and review
14. Neurofibrillary pathology in progressive supranuclear palsy (PSP)
15. Differential expression of exon 10 and 11 in normal tau and tau associated with paired helical filaments
16. Tau gene mutation G389R causes a tauopathy with abundant Pick body-like inclusions and axonal deposits
17. Over-expression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease
18. Research goals in progressive supranuclear palsy
19. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: Tau pathologies with exclusive "exon 10" isoforms
20. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: Expansion of the disease phenotype caused by tau gene mutations
21. Genetic evidence for the involvement of tau in progressive supranuclear palsy
22. Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: Differentiation from progressive supranuclear palsy
23. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites
24. Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy
25. Ultrastructure of neurofibrillary tangles in Steele-Richardson-Olszewski syndrome
26. Unusual paired helical filaments in progressive supranuclear palsy
27. Biochemical mapping of neurofibrillary degeneration in a case of progressive supranuclear palsy: Evidence for general cortical involvement
28. Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease
29. Epitopes that span the tau molecule are shared with paired helical filaments
30. Monoclonal antibody AT8 recognizes tau protein phosphorylated at both serine202 and threonine205
31. Detection of phosphorylated Ser262 in fetal tau, adult tau, and paired helical filament tau
32. Different distribution of phosphorylated tau protein in Alzheimer's and Pick's diseases
33. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396-404
34. The structural basis of monoclonal antibody Alz50's selectivity for Alzheimer's disease pathology
35. A double labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease
36. Biochemical isolation and characterization of paired helical filaments
37. Ubiquitin immunoreactivity of paired helical filaments differs in Alzheimer's disease and corticobasal degeneration
38. Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging
39. Distribution of cortical neurofibrillary tangles in progressive supranuclear palsy
40. Neuropathologic overlap of progressive supranuclear palsy, Pick's disease and corticobasal degeneration
41. Ultrastructural characterization of the tau-immunoreactive tubule in the oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy
42. Abnormal phosphorylation of the microtubule associated protein tau in Alzheimer cytoskeletal pathology
43. The fine structure of subcortical neurofibrillary tangles in progressive supranuclear palsy
44. Ultrastructural and immunochemical study of "astrocytic tangles" (ACT) in patients with progressive supranuclear palsy
45. Substructure of 20 nm filaments of progressive supranuclear palsy
46. Ultrastructural instability of paired helical filaments from corticobasal degeneration as examined by scanning transmission electron microscopy
47. Paired helical filaments in corticobasal degeneration: The fine fibrillary structure with Nano Van
48. Neurofibrillary tangles in progressive supranuclear palsy contain the same tau epitopes identified in Alzheimer's disease PHFtau
49. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans
50. Structural analysis of Pick's disease derived and in vitro-assembled tau filaments
51. Induction of Alzheimer-specific tau epitope AT100 in apoptotic human fetal astrocytes
52. Functional implications for the microtubule-associated protein tau: Localization in oligodendrocytes
53. Role of glycosaminoglycans in determining the helicity of paired helical filaments
54. Assembled tau filaments differ from native paired helical filaments as determined by scanning transmission electron microscopy
55. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes
56. Tau gene mutation K257T causes a tauopathy similar to Pick's disease
57. Pick's disease: Hyperphosphorylated tau protein segregates to the somatoaxonal compartment
58. Neuronal and glial tau-positive inclusions in diverse neurologic diseases share common phosphorylation characteristics